SINGAPORE,, June 11, 2025 / Prnewswire/ – MGI Tech Co., Ltd. (“MGI”), A Company Dedicated to Developing Core Tools and Technologies that drive innovation in life Sciences, and Asia Pathogen Genomics Initiative (“Asia PGI”), part of the Duke-Nus Center for Outbreak Preparedness (COP), Have Recently Announced Collaboration Ahancing Pathogen Genomics SEQUENCING INFORTS ACROSS Asia. This collaboration highlights a common commitment to support public health initiatives thanks to the advanced technology of the life sciences.
As part of this collaboration, MGI and Asia will jointly democratize the sequencing technology of pathogenic genomics in Singapore and through Asia. Collaboration efforts will include the accommodation of webinaries to provide practical knowledge in the sequencing of the genomics of pathogens and providing practical technical training to institutions and laboratories aimed at improving the development of capacity in the detection of pathogens.
In addition, MGI also announced the launch of MGI APAC Pandemic PREPAREDNES Program (PPP) to strengthen the capacities of genomic institutions and laboratories in the supervision of pathogens. In collaboration with Asia PGI, the PPP aims to expand the scope of pathogenic surveillance solutions available for partner countries. The program offers a differentiated and sustainable alternative, focusing on application -oriented solutions and focused on workflows. For example, it supports the development of fair, effective, relevant and validated work flow solutions to treat acute infectious diseases.
“At the Duke-Nu Center for Ourzak Preparation, we believe that equitable access to the genomic sequencing of pathogens is fundamental to strengthen health security in the South and Southeast Asia“said Paul PronykDirector of the cop. “By collaborating with industry partners such as MGI, we are committed to ensuring that all the communities in our region benefit from the latest advances in the genomics of pathogens – allowing early detection, informed response and, ultimately, a healthier future for all.”
“We are proud to associate with Asia PGI to accelerate the application of advanced sequencing technology in the genomics of pathogens,” said Roy TanManaging Director of MGI Asia Pacific. “Control of pathogens is an urgent challenge for many countries Asia. This partnership aims to improve the accessibility of the genomics of pathogens, to empower researchers and public health professionals in their fight against infectious diseases. “”
In response to the growing demand for rapid and precise detection of infectious diseases, MGI has developed a diversified range of complete products for various applications, including metagenomic sequencing, targeted sequencing and sequencing the whole genome of pathogenic microorganisms. For the future, MGI undertakes to continue its innovation, by providing automated, practical and effective basic tools for the identification of pathogens, analysis of drug resistance and traceability.
For more information on PPP, please visit: https://en.mgitech.cn/home/applications/index/id/23.html
About the Duke-Nu Center for Epiber Preparation (COP) and its Asia Pathogen Genomic Initiative (Asia PGI)
The Duke-NUS Center for Ourzak Preparedness (COP) was created in 2022 to meet the growing need for preparation and increased response to epidemics of infectious diseases in the Asian region. With a mission to fill the gap between research, training, politics and practice, the COP aims to improve regional health security in the South and Southeast Asia.
The pathogenic genomic initiative of Asia (Asia PGI) is a flagship initiative of the COP, aimed at exploiting scientific and technical partnerships through Singapore And Asia To advance genomic sequencing for the elimination of infectious diseases.
For more information, please visit https://www.duke-nus.edu.sg/cop
About the Duke-Nu Medicine School
Duke-Nu is Singapore School of flagship medicine of graduates, created in 2005 with a strategic partnership led by the government between two world class institutions: Duke University Medical school and National University of Singapore (Naked). Thanks to an innovative study program, Duke-NU students are fed to become “clinicians” and clinicians ” Singapore and beyond. A leader in revolutionary research and translational innovation, Duke-NU has acquired international renown through its five research programs and 10 centers. The sustainable impact of its discoveries is amplified by its successful partnership in academic medicine with Singapore Health Services (Singhealth), Singapore The largest health care group. This strategic alliance has caused 15 academic clinical programs, which exploit multidisciplinary research and education to transform medicine and improve life.
For more information, please visit www.duke-nu.edu.sg
About MGI
MGI Tech Co., Ltd. (or its subsidiaries, together called MGI) undertakes to create basic tools and technologies that stimulate innovation in life sciences. Our objective lies in research and development, manufacturing and sales of instruments, reagents and related products in the field of life and biotechnology sciences. We provide real-time, multi-ordinary time and a full range of equipment and digital systems for precision medicine, agriculture, health care and various other industries.
Founded in 2016, MGI has become a leader in life sciences, serving customers on six continents and establishing research, manufacturing, training and sales services after sales. MGI stands out as one of the few companies capable of developing independently of sequencers of clinical quality genes with variable flow capacities, ranging from GB to TB levels. With unrivaled expertise, advanced products and commitment to the world’s impact, MGI continues to shape the trajectory of life sciences in the future.
For more information, please visit MGI website or connect with us on Twitter,, Liendin Or YouTube.
Show original content to download the multimedia:https://www.prnewswire.com/apac/news-releases/mgi-tech-partners-with-sia-pathogenic-genomics-initiative-to-dvance-pathogène-genomics-for-public-health-in-asia-302478749.html
Source MGI Tech
